Two Sigma Advisers
SONM icon

Two Sigma Advisers’s DNA X Inc SONM Stock Holding History

Two Sigma Advisers’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-117
Closed -$19K – 2892
2021
Q4 		$19K Buy
+117
New +$35.5K ﹤0.01% 2548
2021
Q3 		– Sell
-51
Closed -$51K – 2658
2021
Q2 		$51K Sell
51
-43
-46% -$46.8K ﹤0.01% 2380
2021
Q1 		$138K Sell
94
-130
-58% -$229K ﹤0.01% 2407
2020
Q4 		$292K Buy
224
+66
+42% +$72.1K ﹤0.01% 2050
2020
Q3 		$221K Buy
158
+148
+1,480% +$238K ﹤0.01% 2121
2020
Q2 		$15K Buy
+10
New +$16K ﹤0.01% 2467

Other funds holding SONM

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's SONM Position: Q1 2022 in Review

Two Sigma Advisers sold out of DNA X Inc (SONM) in Q1 2022, closing a stake of 117 shares — an estimated $19K sold.

Two Sigma Advisers first reported a position in SONM in Q2 2020 and held it in 6 quarters. The position peaked at $292K in Q4 2020. 13 funds tracked by Wall St. Rank hold SONM as of Q1 2022.

  • Two Sigma Advisers reported no remaining DNA X Inc position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 117 DNA X Inc shares in Q1 2022, an estimated $19K.
  • Two Sigma Advisers first reported a position in DNA X Inc in Q2 2020 and held it in 6 quarters.
  • Two Sigma Advisers's DNA X Inc position peaked at $292K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.